相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuroglia in neurodegeneration
Michael T. Heneka et al.
BRAIN RESEARCH REVIEWS (2010)
Adenosine signaling and function in glial cells
D. Boison et al.
CELL DEATH AND DIFFERENTIATION (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Glutathione dysregulation and the etiology and progression of human diseases
Nazzareno Ballatori et al.
BIOLOGICAL CHEMISTRY (2009)
A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
Kaoru Saijo et al.
CELL (2009)
The genetics of Parkinson's syndromes: a critical review
John Hardy et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Well-Water Consumption and Parkinson's Disease in Rural California
Nicole M. Gatto et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Dopamine Transporter Genetic Variants and Pesticides in Parkinson's Disease
Beate R. Ritz et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Novel investigational adenosine A2A receptor antagonists for Parkinson's disease
Annalisa Pinna
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
The Nrf2-ARE cytoprotective pathway in astrocytes
Marcelo R. Vargas et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1
Jens Waak et al.
FASEB JOURNAL (2009)
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
Truyen Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease
Merja H. Voutilainen et al.
JOURNAL OF NEUROSCIENCE (2009)
Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
Banafsheh Kadkhodaei et al.
JOURNAL OF NEUROSCIENCE (2009)
The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism
Chadwick W. Christine et al.
JOURNAL OF NEUROSURGERY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Purinoceptors on Neuroglia
Alexei Verkhratsky et al.
MOLECULAR NEUROBIOLOGY (2009)
Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
Kristen A. Malkus et al.
MOLECULAR NEURODEGENERATION (2009)
Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
Adenosine, adenosine A2A antagonists, and Parkinson's disease
P. Jenner et al.
PARKINSONISM & RELATED DISORDERS (2009)
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
Pei-Chun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway
Mei Cui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Is Parkinson's disease a prion disorder?
C. Warren Olanow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Purinergic signalling in the nervous system: an overview
Maria P. Abbracchio et al.
TRENDS IN NEUROSCIENCES (2009)
Glutathione and Parkinson's disease: Is this the elephant in the room?
Gail D. Zeevalk et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease
Kien Trinh et al.
JOURNAL OF NEUROSCIENCE (2008)
Glial dysfunction in parkin null mice:: Effects of aging
Rosa M. Solano et al.
JOURNAL OF NEUROSCIENCE (2008)
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
Ivar Mendez et al.
NATURE MEDICINE (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Research in motion: the enigma of Parkinson's disease pathology spread
Patrik Brundin et al.
NATURE REVIEWS NEUROSCIENCE (2008)
A Nurr1 point mutant, implicated in Parkinson's disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription
Kirsten X. Jacobsen et al.
NEUROBIOLOGY OF DISEASE (2008)
Glial Cells as Players in Parkinsonism: The Good, the Bad, and the Mysterious Glia
Maria A. Mena et al.
NEUROSCIENTIST (2008)
MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
Jyothi K. Mallajosyula et al.
PLOS ONE (2008)
Emerging restorative treatments for Parkinson's disease
Tomas Deierborg et al.
PROGRESS IN NEUROBIOLOGY (2008)
Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes
David N. Bowser et al.
JOURNAL OF GENERAL PHYSIOLOGY (2007)
The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system
Claudia Grothe et al.
BRAIN RESEARCH REVIEWS (2007)
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2007)
Point source concentration of GDNF may explain failure of phase II clinical trial
Michael F. Salvatore et al.
EXPERIMENTAL NEUROLOGY (2006)
Targeting adenosine A2A receptors in Parkinson's disease
Michael A. Schwarzschild et al.
TRENDS IN NEUROSCIENCES (2006)
DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2
Casey M. Clements et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Evolution of increased glia-neuron ratios in the human frontal cortex
Chet C. Sherwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of a potent agonist of the orphan nuclear receptor Nurr1
Celine Dubois et al.
CHEMMEDCHEM (2006)
Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: Role of neuron-glia crosstalk
Ana Saavedra et al.
NEUROBIOLOGY OF DISEASE (2006)
Diagnosis and treatment of Parkinson disease: molecules to medicine
Joseph M. Savitt et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Translated mutation in the Nurr1 gene as a cause for Parkinson's disease
David A. Grimes et al.
MOVEMENT DISORDERS (2006)
Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease
C. Warren Olanow
NEUROLOGY (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease
AJ Whitworth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse
M Pierri et al.
NEUROPHARMACOLOGY (2005)
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease
J Jankovic et al.
PROGRESS IN NEUROBIOLOGY (2005)
Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult
AD Kraft et al.
JOURNAL OF NEUROSCIENCE (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
R Bandopadhyay et al.
BRAIN (2004)
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
M Koistinaho et al.
NATURE MEDICINE (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation
S Hague et al.
ANNALS OF NEUROLOGY (2003)
Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?
ME Gegg et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis
JM Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Mutations in NR4A2 associated with familial Parkinson disease
WD Le et al.
NATURE GENETICS (2003)
Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones
J Hirrlinger et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Glutathione release from cultured brain cells: Multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells
J Hirrlinger et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: A randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial
I Shoulson et al.
ANNALS OF NEUROLOGY (2002)
Oxidatively modified proteins in aging and disease
MF Beal
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Neuroprotection by adenosine A(2A) receptor blockade in experimental models of Parkinson's disease
K Ikeda et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
A Ascherio et al.
ANNALS OF NEUROLOGY (2001)
Association of coffee and caffeine intake with the risk of Parkinson disease
GW Ross et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains
K Wakabayashi et al.
ACTA NEUROPATHOLOGICA (2000)
分享论文
